ArticleIrish journal of medical science2026
Using a cardiac registry to highlight multidisciplinary care in pregnancy.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiac disease in pregnancy is linked to significant maternal and fetal risks. A cardiac registry provides a way to systematically collect data on pregnant women with cardiac disease, enabling analysis of outcomes, care approaches, and the development of improved clinical protocols.
aimTo assess the role of a Pregnancy Heart Team (PHT) in managing cardiac disease during pregnancy, using data from a newly established registry at the National Maternity Hospital (NMH).
methodsThis was a prospective study analysing registry data from women attending the joint obstetric-cardiology clinic at NMH between January 2021 and September 2024. The registry included pregnant and pre-pregnancy patients. Demographics, cardiac diagnoses, risk classification, and maternal and neonatal outcomes were collected.
resultsA total of 111 women with cardiac disease were captured, encompassing 153 pregnancies. Most women (87.6%, n = 134) had pre-existing cardiac disease, while 12.4% (n = 19) were newly diagnosed during pregnancy. Rhythm disorders were the most common diagnosis (60.3%, n = 91). 12.4% (n = 19) of women received pre-conceptual counselling. Risk stratification using the modified World Health Organization (mWHO) classification showed that 33.3% (n = 44) were class I, 34.1% (n = 45) class II, 25% (n = 33) class II-III, and 7.6% (n = 10) class III; no women were classified as mWHO IV. Cardiac events occurred in 16.4% (n = 26), most frequently in the third trimester (42.3%, n = 11), highlighting this as a high-risk period.
conclusionsRegistry findings highlights the importance of early, structured PHT care, to ensure optimal maternal and fetal outcomes.
Indexed as
Identifiers
42247091What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.